From October 16th to 18th 2019 we have attended the 64th EUHA (European Association of Hearing Acousticians) congress in Nuremberg, Germany. With more than 8’000 participants, 140 exhibitors and 20 expert lectures the EUHA congress is among the largest in the world in this field.
For the major hearing aid manufacturers, the focus this year was on form factor or category additions to existing platforms rather than new launches (Sivanto’s “Xperience” being the exception). With current platform cycles of 2 to 3 years, this was highly expected, as the current technology platforms in place are relatively young in age (Widex Evoke launched in April 2018 and being the oldest in the peer group).
The MSCI World Healthcare NR Index returned -2.7% in February, while the MSCI World NR Index rose 2.6%. During the last week of the month, many sectors took a hit because of rising 10-year Treasury rates (now at their highest levels in a year), enhancing on one hand the attractiveness of bonds vs. Equities and on the other hand propelling cyclical stocks.
Healthcare started 2021 on a very positive note, outperforming most of the other sectors (Energy, 3.0%, being the sole exception). The MSCI World Healthcare Net Return (NR) Index gained 1.1% in January 2021, while the MSCI World NR Index declined 1.0%.
The MSCI World Healthcare Net Return (NR) Index rose by 9.0% in November 2020 and the MSCI World NR Index gained 12.8%. November was the best month for global equities year-to-date (12.8%), with cyclicals outperforming defensive sectors.